EURONEXT:BETR
A Better Life Pharma
- Stock
Market Cap
14.69M
Beta: 1.42
Volume Today
19.20K
Avg: 160.13K
PE Ratio
−4.23
PFCF: −4.62
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jan '14 | Jan '15 | Jan '16 | Jan '17 | Jan '18 | Jan '19 | Jan '20 | Jan '21 | Jan '22 | Jan '23 | Jan '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.01 - | -0.03 614.99% | 23.19K 76,794,880.01% | |||||||||
cash per share | 0.00 - | 0.00 325.44% | 0.01 1,300.72% | 0.02 51.82% | 0.01 49.08% | 0.01 16.75% | 0.18 2,050.76% | 0.01 96.79% | 0.00 59.84% | 0.00 95.83% | 0.00 256.45% | |
company equity multiplier | -0.01 - | -0.02 142.78% | -0.32 1,291.23% | -0.09 72.10% | -8.46 9,299.17% | 2.45 128.96% | 3.11 26.81% | -0.29 109.33% | -0.30 3.28% | -0.01 97.67% | -0.03 331.35% | |
days of inventory outstanding | ||||||||||||
days of payables outstanding | 826.06 - | |||||||||||
days of sales outstanding | 1.04K - | -4.70K 553.92% | 0.00 100.00% | |||||||||
dividend yield | ||||||||||||
ebit per revenue | -387.15 - | 196.13 150.66% | -0.00 100.00% | |||||||||
ebt per ebit | 9.80 - | 7.66 21.84% | 1.00 86.97% | 1.04 4.40% | 0.12 88.92% | 1.34 1,057.11% | 1.05 21.75% | 4.59 339.14% | 1.17 74.42% | 0.99 15.67% | 0.90 8.85% | |
effective tax rate | -0.13 - | -0.22 72.22% | 0.02 - | -0.15 953.46% | 0.15 199.56% | -0.02 115.91% | 0.00 100.03% | -0.01 195,908.32% | 0.03 341.21% | 0.00 90.25% | ||
enterprise value multiple | -90.56 - | -10.23 88.71% | -8.14 20.38% | -1.40 82.84% | -156.41 11,096.19% | -4.35 97.22% | -3.01 30.91% | -5.36 78.30% | -1.51 71.88% | -1.51 0.01% | -2.62 73.51% | |
fixed asset turnover | 0.01 - | -1.09 8,678.59% | 1.46M 133,474,159.59% | |||||||||
free cash flow per share | -0.01 - | -0.05 703.72% | -0.03 35.06% | -0.07 122.93% | -0.06 7.07% | -0.65 958.24% | -0.56 13.34% | -0.27 52.04% | -0.15 44.75% | -0.02 88.30% | -0.02 30.25% | |
gross profit margin | 1 - | 1 0% | 1 0% | |||||||||
interest coverage | -0.78 - | -0.58 25.72% | -516.56 - | -38.31 92.58% | -7.59 80.20% | -43.69 475.74% | -197.39 351.85% | -174.96 11.37% | -140.83 19.51% | -63.07 55.22% | ||
inventory turnover | ||||||||||||
long term debt to capitalization | 0.64 - | -0.30 - | -0.04 85.81% | -0.02 45.74% | ||||||||
net income per ebt | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1.02 2.44% | 1.00 2.38% | 1.01 1.39% | 0.97 4.68% | 1.00 3.13% | |
net profit margin | -414.74 - | 900.70 317.17% | -0.00 100.00% | |||||||||
operating cash flow per share | -0.01 - | -0.05 703.72% | -0.03 35.06% | -0.07 122.93% | -0.06 7.07% | -0.55 803.38% | -0.52 5.02% | -0.27 49.42% | -0.15 44.01% | -0.02 88.30% | -0.02 30.25% | |
operating profit margin | -387.15 - | 196.13 150.66% | -0.00 100.00% | |||||||||
payables turnover | 0.44 - | |||||||||||
pretax profit margin | -404.88 - | 900.71 322.46% | -0.00 100.00% | |||||||||
price fair value | -5.02 - | -10.53 109.66% | -212.54 1,917.68% | -5.48 97.42% | -3.54K 64,513.52% | 5.96 100.17% | 8.00 34.27% | -9.04 212.93% | -4.02 55.54% | -1.19 70.38% | -0.76 36.30% | |
receivables turnover | 0.35 - | -0.08 122.03% | 82.87K 106,803,803.41% | |||||||||
return on assets | -105.19 - | -622.69 491.98% | -80.84 87.02% | -47.33 41.46% | -0.32 99.33% | -1.06 237.01% | -2.43 128.56% | -27.20 1,018.41% | -10.47 61.51% | -121.22 1,057.83% | -8.90 92.66% | |
return on capital employed | 0.11 - | 1.88 1,668.26% | 26.12 1,286.58% | 4.09 84.36% | 23.12 465.87% | -1.95 108.43% | -2.57 31.75% | 1.75 168.30% | 3.42 95.09% | 1.34 60.93% | 0.49 63.09% | |
return on equity | 1.00 - | 14.44 1,337.24% | 26.08 80.62% | 4.26 83.67% | 2.67 37.30% | -2.61 197.60% | -7.55 189.84% | 7.88 204.34% | 3.13 60.25% | 0.84 73.05% | 0.27 68.34% | |
total debt to capitalization | -0.84 - | -0.23 - | 1.29 663.13% | 0.50 61.35% | 0.64 28.02% | -0.12 119.03% | -0.56 361.92% | -0.12 77.84% | -0.02 81.34% |
All numbers in USD (except ratios and percentages)